MoneyWorks4Me

Aurobindo Pharma informs about investors meet

23 Feb 2022 Evaluate

Aurobindo Pharma has informed that S. Subramanian, Chief Financial Officer of the Company, will be participating in virtual event of investors' meet organized by Kotak Institutional Equities on February 24,2022. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. This information is submitted pursuant to Regulation 30(6) of the Listing Regulations.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1752.50
Dr. Reddys Labs. 1180.00
Cipla 1305.00
Lupin 1942.00
Zydus Lifesciences 1115.20
View more..